Profound Medical
PROF
32 hedge funds and large institutions have $71.7M invested in Profound Medical in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 5 closing their positions.
1,636% more call options, than puts
Call options by funds: $243K | Put options by funds: $14K
3.58% less ownership
Funds ownership: 40.59% → 37.01% (-3.6%)
6% less funds holding
Funds holding: 34 → 32 (-2)
22% less capital invested
Capital invested by funds: $91.7M → $71.7M (-$20M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$2.26M |
| 2 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
+$1.04M |
| 3 |
RA
Royce & Associates
New York
|
+$265K |
| 4 |
Jane Street
New York
|
+$202K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$49.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$8.93M |
| 2 |
ZDA
Zweig-DiMenna Associates
New York
|
-$994K |
| 3 |
GS
Gagnon Securities
New York
|
-$667K |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$440K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$401K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $6.5K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $3K | +$3.66K | +316 | New |
|
|
HIA
28
Harbor Investment Advisory
Lutherville,
Maryland
| $2.31K | – | – | – |
|
|
BAM
29
Belpointe Asset Management
Reno,
Nevada
| $1.73K | – | – | – |
|
30
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $1K | – | – | – |
|
31
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1K | +$1.3K | +112 | New |
|
|
PA
32
Parallel Advisors
San Francisco,
California
| $279 | – | – | – |
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$345K | -29,832 | Closed |
|
|
CAG
34
Crestwood Advisors Group
Boston,
Massachusetts
| – | -$201K | -18,500 | Closed |
|
|
SWA
35
Sutton Wealth Advisors
Tampa,
Florida
| – | -$54.5K | -5,000 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | -$22.5K | -2,066 | Closed |
|
37
Group One Trading
Chicago,
Illinois
| – | -$2.01K | -174 | Closed |
|
PROF Hedge Fund Activity: Q1 2023 in Review
32 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2023, worth a combined $71.7M — down 22% from $91.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PROF and 3 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $2.26M. The largest seller was National Bank of Canada, cutting an estimated $8.93M.
- 32 institutional investors held Profound Medical (PROF) as of Q1 2023, down from 34 in Q4 2022.
- Funds reported $71.7M of Profound Medical stock for Q1 2023, down 22% quarter-over-quarter.
- 3 funds opened new Profound Medical positions in Q1 2023 and 5 closed out, a net change of -2 holders.
- The largest Profound Medical buyer in Q1 2023 was Raymond James Financial Services Advisors, an estimated $2.26M added.
- The largest Profound Medical seller in Q1 2023 was National Bank of Canada, an estimated $8.93M sold.
Based on aggregated 13F filings for Q1 2023.